• Publications
  • Influence
Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial.
TLDR
The use of IVUS-guided everolimus-eluting stent implantation, compared with angiography-guided stent implants, resulted in a significantly lower rate of the composite of major adverse cardiac events at 1 year, primarily due to lower risk of target lesion revascularization.
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial.
TLDR
Among patients with acute coronary syndromes treated with drug-eluting stents, ticagrelor monotherapy after 3 months of dual antiplatelet therapy, compared with ticagerelor-based 12-month dual anti Platelet therapy resulted in a modest but statistically significant reduction in a composite outcome of major bleeding and cardiovascular events at 1 year.
Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary
TLDR
High pre-intervention PLR and NLR, especially when combined, are independent predictors of long-term adverse clinical outcomes such as all-cause mortality, cardiac death, and myocardial infarction in patients with unstable angina and NSTEMI who have undergone successful PCI with DES.
Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions
TLDR
PCB treatment of de novo coronary lesions showed better 9-month angiographic outcomes than POBA treatment alone, and was compared to plain old balloon angioplasty alone.
Prediction of Left Atrial Fibrosis With Speckle Tracking Echocardiography in Mitral Valve Disease: A Comparative Study With Histopathology
TLDR
Left atrial strain as measured by speckle tracking echocardiography might be helpful for predicting the degree of LA fibrosis in patients with MV disease.
Current Management of In-Stent Restenosis
TLDR
This review will discuss the currently available therapeutic strategies for the management of patients with in-stent restenosis and the evidence supporting their use.
Effects of Atorvastatin 20 mg, Rosuvastatin 10 mg, and Atorvastatin/Ezetimibe 5 mg/5 mg on Lipoproteins and Glucose Metabolism
TLDR
3 statin regimens have differential effect on apolipoprotein B/A1 and glycemic control after comparable LDL-C reduction and homeostasis model assessment-insulin resistance (HOMA-IR).
...
...